14 August 2022 in World Neurosurgery
17 April 2023 in World Neurosurgery
6 April 2024 in World Neurosurgery
31 March 2026 in Journal of Cerebrovascular and Endovascular Neurosurgery
Objective: We aimed to investigate the predictors of aneurysm occlusion following flow diversion treatment for unruptured intracranial aneurysms (UIA) using the Surpass Evolve (SE) stent.Methods: The radiological and clinical outcomes of UIAs treated using SE stent at a single tertiary hospital were reviewed retrospectively. We categorized radiological outcome into the poor (O’Kelly-Marotta [OKM] grade A-B) and favorable occlusion group (OKM grade C-D). Univariate and multivariate analyses were conducted to identify risk factors associated with poor occlusion.Results: A total of 68 unruptured intracranial aneurysms in 52 patients were treated in our institution from December 2019 to July 2024. At last radiological follow-up (mean 17.5±10.1 months), the overall favorable occlusion rate was 79.4% (n=52). Multivariate analysis showed larger aneurysm (p=0.011, OR=0.89, 95% CI [0.81-0.98]) and presence of incorporated branch (p=0.007, OR=8.26, 95% CI [1.78-38.28]) were associated with independent factors for poor occlusion, respectively. Procedural mortality and morbidity were 0% (n=0) and 1.9% (n=1). One patient presented with delayed ischemic stroke (1.9%, n=1) without permanent neurological deficit.Conclusions: Treatment for UIAs using the Surpass Evolve flow-diverting stent might be feasible for efficacy and safety. In this study, larger size of aneurysm and branch incorporated aneurysm were associated with poor occlusion after flow-diversion using SE stent.
30 May 2025 in Journal of NeuroInterventional Surgery
Background The cumulative impact of radiation dose reduction strategies in acute hospital settings remains underreported. This study quantifies and compares cumulative radiation exposure in patients with ruptured intracranial aneurysms before and after implementing dose reduction strategies. Methods This retrospective study included 166 patients with subarachnoid hemorrhage (SAH) due to ruptured intracranial aneurysms, comparing two time periods: pre-adjustment (July 2012–March 2013) and post-adjustment (January 2017–March 2022) of dose reduction strategies. Radiation doses from imaging modalities, including X-ray, computed tomography (CT), and angiography, were collected. Cumulative radiation dose (CRD) and cumulative effective dose (CED) were calculated and compared between the two periods. Results Angiography accounted for the largest share of the CRD in clipping and coiling procedures (about 75% and 95%, respectively), whereas its contribution to the CED was lower in clipping and coiling procedures (about 20 and 60%, respectively), reflecting differences in radiation weighting for biological effects. Significant reductions in both mean CRD and CED were observed in the post-period for both clipping and coiling procedures, with reductions of approximately 40% and 30% in CRD (P<.001 and P=0.013) and 45% and 35% in CED (P< .001 and P=0.002), respectively. Conclusion The implementation of radiation dose reduction strategies significantly decreased both cumulative radiation and effective doses, highlighting the importance of continuous optimization to enhance patient safety without compromising diagnostic and therapeutic efficacy.
1 January 2026 in Journal of Korean Neurosurgical Society
Objective : To investigate the clinical and radiological features of unruptured vertebral artery dissecting aneurysms (uVADAs) treated with reconstructive endovascular techniques and to evaluate the risk factors associated with unfavorable radiological outcomes while focusing on the flow diversion effect.Methods : We retrospectively reviewed 86 patients with uVADAs treated at a single tertiary center between January 2009 and December 2022. The patients were categorized into the flow diversion group (patients with uVADAs treated with a flow diverter or multiple stents) and the non-flow diversion group (patients with one or fewer stent insertion). Unfavorable angiographic outcomes were defined as 1) recurrence after coil insertion regardless of stent deployment or 2) no regression after stent insertion without coil packing. Univariate and multivariate analyses were performed to assess the related risk factors.Results : We observed 37 uVADAs in the flow diversion group. Recurrence or no regression occurred in two of 37 (9.1%) and 13 of 49 (27.7%) uVADAs in the flow and non-flow diversion groups, respectively. The treatment without flow diversion effect (non-flow diversion group; odds ratio [OR], 8.04; 95% confidence interval [CI], 1.23–52.57; p=0.003) and hypertension (OR, 22.09; 95% CI, 2.51–194.2; p=0.005) were significantly associated with unfavorable angiographic outcomes.Conclusion : The flow diversion effect using a flow diverter or multiple stents insertion, along with strict blood pressure control, may be an important factor in achieving favorable angiographic outcomes in uVADA treatment.